Mygenic Healthcare Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Mygenic Healthcare Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $79.4K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Mygenic Healthcare Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $79.4K Trade | TransData Nexus

Mygenic Healthcare Private Limited

Indian Pharmaceutical Exporter · Advanced Oncology Specialist · $79.4K Total Trade · DGFT Verified

Mygenic Healthcare Private Limited is an Indian pharmaceutical exporter with a total trade value of $79.4K across 2 products in 1 therapeutic categories. Based on 30 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Pazopanib ($59.7K), Fludarabine ($19.7K), .

Mygenic Healthcare Private Limited — Export Portfolio & Destination Treemap

Mygenic Healthcare Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Mygenic Healthcare Private Limited? — Company Overview & Market Position

Mygenic Healthcare Private Limited is a privately held pharmaceutical company established on August 14, 2020, in Navi Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U85100MH2020PTC343851. Its authorized and paid-up capital is ₹100,000 each. The registered office is located at Office No.-02, Dolphin Platinum, Plot No.-98, Sector-35, Kamothe, Navi Mumbai, Maharashtra, 410209.

As of March 2025, the company is led by Directors Rupesh Kumar Gupta and Nilam Kumari Rupesh Kumar Gupta. The latest Annual General Meeting (AGM) was held on September 30, 2024, with the balance sheet filed on March 31, 2024.

Mygenic Healthcare specializes in the export of pharmaceutical formulations, including tablets, capsules, syrups, and injections, focusing on the oncology therapeutic category. The company has reported a total export value of $79,000 USD across 30 shipments, with Pazopanib and Fludarabine being the top exported products.

What Does Mygenic Healthcare Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Pazopanib$59.7K

Product Portfolio — Top 2 by Export Value

Mygenic Healthcare Private Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Pazopanib	Advanced Oncology	$59.7K	21	0.7%	6
2	Fludarabine	Advanced Oncology	$19.7K	9	0.7%	9

Mygenic Healthcare Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $79.4K. The top category is Advanced Oncology (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Mygenic Healthcare Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

The company operates manufacturing facilities in Navi Mumbai, Maharashtra, India. While specific details regarding plant capacities and specializations are not publicly disclosed, Mygenic Healthcare emphasizes the use of state-of-the-art technologies and adherence to industry regulations and quality standards in its manufacturing processes.

3Key Leadership

The leadership team comprises Directors Rupesh Kumar Gupta and Nilam Kumari Rupesh Kumar Gupta. Rupesh Kumar Gupta has been associated with the company since its inception on August 14, 2020. Nilam Kumari Rupesh Kumar Gupta joined as a Director on March 28, 2025.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Mygenic Healthcare Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Mygenic Healthcare's export activities are primarily focused on the oncology therapeutic category, with Pazopanib and Fludarabine being the top exported products. The company has reported a total export value of $79,000 USD across 30 shipments.

2Emerging Markets

3Geographic Strategy

TransData Nexus Research · FDA, EMA, WHO, MHRA, TGA databasesMar 2026

Mygenic Healthcare Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Mygenic Healthcare's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company emphasizes adherence to industry regulations and quality standards in its manufacturing processes.

2WHO & EU GMP

Information regarding Mygenic Healthcare's World Health Organization (WHO) prequalification, European Union Good Manufacturing Practice (EU GMP) certificates, and European Directorate for the Quality of Medicines & HealthCare (EDQM) status is not publicly disclosed. The company emphasizes adherence to industry regulations and quality standards in its manufacturing processes.

3CDSCO & Indian Regulatory

Specific details regarding Mygenic Healthcare's Central Drugs Standard Control Organisation (CDSCO) manufacturing licenses, state drug controller approvals, and export No Objection Certificates (NOCs) are not publicly available. The company emphasizes adherence to industry regulations and quality standards in its manufacturing processes.

Mygenic Healthcare Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Mygenic Healthcare operates in the competitive pharmaceutical export market, focusing on oncology products such as Pazopanib and Fludarabine. While specific market share data is not publicly available, the company's emphasis on high-quality products and adherence to industry standards positions it as a competitive player in the market.

2Key Differentiators

Mygenic Healthcare's key differentiators include its focus on high-quality pharmaceutical formulations, particularly in the oncology therapeutic category, and its commitment to adhering to industry regulations and quality standards in its manufacturing processes.

3Strategic Position

Mygenic Healthcare's current strategic direction focuses on exporting high-quality pharmaceutical formulations, particularly in the oncology therapeutic category. The company's emphasis on adherence to industry regulations and quality standards positions it for potential growth in the global pharmaceutical export market.

Buyer Due Diligence Brief — Evaluating Mygenic Healthcare Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Approval: Confirm that the products are approved by the U.S. Food and Drug Administration. Verification can be done through the FDA's official website or by contacting the FDA directly.

WHO-GMP Certification: Ensure that the manufacturing facilities comply with World Health Organization's Good Manufacturing Practice standards. This can be verified by checking the WHO's official website or contacting the organization.

EU GMP Certification: Verify that the products meet European Union Good Manufacturing Practice standards. This can be done by consulting the European Medicines Agency (EMA) or the relevant national regulatory authorities.

Frequently Asked Questions — Mygenic Healthcare Private Limited

How many pharmaceutical products does Mygenic Healthcare Private Limited export from India?

Mygenic Healthcare Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Pazopanib ($59.7K), Fludarabine ($19.7K). Total export value is $79.4K.

What is Mygenic Healthcare Private Limited's total pharmaceutical export value?

Mygenic Healthcare Private Limited's total pharmaceutical export value is $79.4K, based on 30 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Mygenic Healthcare Private Limited cover?

Mygenic Healthcare Private Limited exports across 1 therapeutic categories. The largest are Advanced Oncology (100.0%, 2 products).

Get Full Mygenic Healthcare Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.